Bank of America
HQL

Bank of America’s abrdn Life Sciences Investors HQL Stock Holding History

Bank of America’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.88M Buy
115,585
+9,145
+9% +$153K ﹤0.01% 4157
2025
Q4 		$1.79M Sell
106,440
-6,566
-6% -$110K ﹤0.01% 4155
2025
Q3 		$1.75M Sell
113,006
-32,255
-22% -$442K ﹤0.01% 4926
2025
Q2 		$1.86M Sell
145,261
-34,790
-19% -$429K ﹤0.01% 4841
2025
Q1 		$2.28M Sell
180,051
-5,411
-3% -$73.3K ﹤0.01% 4570
2024
Q4 		$2.43M Sell
185,462
-9,465
-5% -$137K ﹤0.01% 4278
2024
Q3 		$2.94M Sell
194,927
-22,498
-10% -$340K ﹤0.01% 4225
2024
Q2 		$3.08M Sell
217,425
-19,089
-8% -$258K ﹤0.01% 4060
2024
Q1 		$3.22M Sell
236,514
-18,936
-7% -$262K ﹤0.01% 4035
2023
Q4 		$3.44M Buy
255,450
+147,127
+136% +$1.81M ﹤0.01% 3880
2023
Q3 		$1.35M Buy
108,323
+14,621
+16% +$192K ﹤0.01% 4588
2023
Q2 		$1.27M Buy
93,702
+189
+0.2% +$2.61K ﹤0.01% 4595
2023
Q1 		$1.3M Sell
93,513
-54,812
-37% -$784K ﹤0.01% 4717
2022
Q4 		$2.11M Buy
148,325
+118,509
+397% +$1.72M ﹤0.01% 4210
2022
Q3 		$408K Buy
29,816
+8,354
+39% +$125K ﹤0.01% 5546
2022
Q2 		$306K Buy
21,462
+2,605
+14% +$39.3K ﹤0.01% 5785
2022
Q1 		$312K Sell
18,857
-3,659
-16% -$63K ﹤0.01% 6159
2021
Q4 		$433K Buy
22,516
+208
+0.9% +$4.18K ﹤0.01% 6000
2021
Q3 		$464K Buy
22,308
+2,990
+15% +$64K ﹤0.01% 5707
2021
Q2 		$414K Buy
19,318
+1,450
+8% +$29.3K ﹤0.01% 5571
2021
Q1 		$352K Sell
17,868
-44,551
-71% -$918K ﹤0.01% 5645
2020
Q4 		$1.23M Sell
62,419
-7,278
-10% -$135K ﹤0.01% 4323
2020
Q3 		$1.23M Sell
69,697
-232
-0.3% -$4.15K ﹤0.01% 4047
2020
Q2 		$1.26M Sell
69,929
-29,528
-30% -$506K ﹤0.01% 3967
2020
Q1 		$1.49M Sell
99,457
-6,774
-6% -$111K ﹤0.01% 3714
2019
Q4 		$1.85M Sell
106,231
-14,542
-12% -$239K ﹤0.01% 4067
2019
Q3 		$1.82M Buy
120,773
+18,271
+18% +$293K ﹤0.01% 4132
2019
Q2 		$1.73M Buy
102,502
+7,499
+8% +$124K ﹤0.01% 4150
2019
Q1 		$1.63M Buy
95,003
+29,557
+45% +$510K ﹤0.01% 4148
2018
Q4 		$989K Buy
65,446
+28,045
+75% +$494K ﹤0.01% 4407
2018
Q3 		$764K Buy
37,401
+1,078
+3% +$21.4K ﹤0.01% 4662
2018
Q2 		$682K Sell
36,323
-1,180
-3% -$22.2K ﹤0.01% 4706
2018
Q1 		$721K Sell
37,503
-6,334
-14% -$127K ﹤0.01% 4592
2017
Q4 		$860K Sell
43,837
-3,773
-8% -$75.6K ﹤0.01% 4592
2017
Q3 		$1.02M Buy
47,610
+13,476
+39% +$286K ﹤0.01% 4491
2017
Q2 		$711K Buy
34,134
+2,083
+6% +$42.1K ﹤0.01% 4666
2017
Q1 		$621K Sell
32,051
-3,283
-9% -$60.8K ﹤0.01% 4746
2016
Q4 		$600K Buy
35,334
+2,059
+6% +$36.2K ﹤0.01% 4688
2016
Q3 		$624K Sell
33,275
-2,992
-8% -$56.4K ﹤0.01% 4475
2016
Q2 		$623K Sell
36,267
-10,061
-22% -$186K ﹤0.01% 4511
2016
Q1 		$831K Sell
46,328
-5,988
-11% -$109K ﹤0.01% 4231
2015
Q4 		$1.24M Buy
52,316
+8,338
+19% +$207K ﹤0.01% 4216
2015
Q3 		$990K Buy
43,978
+26,261
+148% +$736K ﹤0.01% 4326
2015
Q2 		$500K Buy
17,717
+8,759
+98% +$243K ﹤0.01% 4694
2015
Q1 		$247K Buy
8,958
+232
+3% +$6.33K ﹤0.01% 4800
2014
Q4 		$217K Buy
8,726
+2,227
+34% +$53.4K ﹤0.01% 5307
2014
Q3 		$144K Buy
6,499
+1,871
+40% +$40.6K ﹤0.01% 5712
2014
Q2 		$96K Buy
4,628
+450
+11% +$9.45K ﹤0.01% 6177
2014
Q1 		$91K Buy
4,178
+92
+2% +$2.05K ﹤0.01% 6059
2013
Q4 		$84K Buy
4,086
+527
+15% +$10.2K ﹤0.01% 6246
2013
Q3 		$69K Sell
3,559
-938
-21% -$18K ﹤0.01% 6222
2013
Q2 		$80K Buy
+4,497
New +$81.2K ﹤0.01% 6288

Other funds holding HQL

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.61B AUM 23.21% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Bank of America's HQL Position: Q1 2026 in Review

Bank of America increased its abrdn Life Sciences Investors (HQL) stake by 8.6% in Q1 2026, buying an estimated $153K and bringing the position to 115,585 shares worth $1.88M. The position accounts for ﹤0.01% of the portfolio, ranked #4157.

Bank of America first reported a position in HQL in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.44M in Q4 2023. 86 funds tracked by Wall St. Rank hold HQL as of Q1 2026.

  • Bank of America held 115,585 shares of abrdn Life Sciences Investors worth $1.88M as of Q1 2026.
  • Bank of America bought 9,145 abrdn Life Sciences Investors shares in Q1 2026, an estimated $153K.
  • abrdn Life Sciences Investors made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #4157 holding.
  • Bank of America first reported a position in abrdn Life Sciences Investors in Q2 2013 and has held it in 52 quarters since.
  • Bank of America's abrdn Life Sciences Investors position peaked at $3.44M in Q4 2023.
  • 86 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.